サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1784061

プロテインA樹脂の世界市場

Protein A Resins

出版日
ページ情報
英文 202 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.16円
プロテインA樹脂の世界市場
出版日: 2025年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 202 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

プロテインA樹脂の世界市場は2030年までに23億米ドルに達する

2024年に17億米ドルと推定されるプロテインA樹脂の世界市場は、2024年から2030年にかけてCAGR 5.5%で成長し、2030年には23億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである組換えプロテインAは、CAGR4.4%を記録し、分析期間終了時には13億米ドルに達すると予想されます。天然プロテインAセグメントの成長率は、分析期間中CAGR 7.1％と推定されます。

米国市場は4億3,900万米ドルと推定、中国はCAGR 5.5％で成長すると予測

米国のプロテインA樹脂市場は、2024年に4億3,900万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを5.5%として、2030年までに3億7,250万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.0％と4.8％と予測されています。欧州では、ドイツがCAGR約4.6%で成長すると予測されています。

世界のプロテインAレジン市場- 主要動向と促進要因まとめ

バイオ医薬品製造においてプロテインA樹脂が重要なのはなぜか？

プロテインA樹脂は、主にモノクローナル抗体（mAbs）を精製するためのアフィニティークロマトグラフィーに使用され、バイオ医薬品製造に不可欠な成分となっています。がん、自己免疫疾患、感染症に対するモノクローナル抗体療法を含む生物製剤に対する需要の高まりが、医薬研究や医薬品開発におけるプロテインA樹脂の広範な採用を後押ししています。この樹脂は高い特異性で抗体を捕捉し精製するのに非常に効果的で、バイオ治療薬の品質と有効性を保証します。バイオ医薬品産業が拡大を続ける中、企業は医薬品の収率を高め、生産コストを削減し、厳しい規制基準を満たすために、高度な精製技術に投資しています。さらに、バイオシミラーや個別化医療の台頭により、効率的な抗体精製ソリューションの需要がさらに高まっており、プロテインA樹脂は現代のバイオプロセスにおいて不可欠なツールとなっています。

プロテインA樹脂市場の成長に影響を与える課題とは？

バイオ医薬品の精製において重要な役割を担っているにもかかわらず、プロテインA樹脂市場は、そのスケーラビリティとコスト効率に影響を与えるいくつかの課題に直面しています。主な懸念事項の1つは、プロテインA樹脂の生産に関連する高コストで、モノクローナル抗体製造の全体的な経費に大きく上乗せされます。樹脂カラムの寿命が限られていることも課題であり、頻繁な交換は運用コストと廃棄物管理の懸念を増大させる。さらに、バイオ医薬品製造における規制遵守の複雑さは、厳格なバリデーションプロセスを必要とし、新しい樹脂技術の採用をさらに遅らせています。また、イオン交換クロマトグラフィーやミックスモードクロマトグラフィーなどの代替精製技術の台頭も、コスト効率と拡張性に優れた選択肢を模索する企業にとって、競争を生み出しています。これらの課題に対処するには、樹脂の再利用性、プロセスの最適化、大規模バイオ生産におけるプロテインA樹脂に代わるコスト効率の高い樹脂の開発において、継続的な進歩が必要です。

クロマトグラフィーとバイオプロセスにおける革新は、どのようにプロテインA樹脂の効率を高めていますか？

クロマトグラフィーとバイオプロセス技術の進歩は、プロテインA樹脂の効率と持続可能性を著しく向上させています。高容量で耐アルカリ性の樹脂の開発により、精製カラムの寿命が延び、樹脂の交換頻度が減り、生産コストが低下しています。また、連続クロマトグラフィーの統合は抗体精製に革命をもたらし、バイオ医薬品メーカーはプロセスの効率を高め、樹脂の使用量を最小限に抑え、製品の収率を向上させることができます。さらに、組換えプロテインAリガンドの進歩により、樹脂の安定性と選択性が向上し、標的分子の損失を最小限に抑えながら精製効率を高めることができます。樹脂開発におけるナノテクノロジーの利用は、結合能力をさらに最適化し、精製時間を短縮することで、抗体製造をよりコスト効率の高いものにしています。バイオ医薬品企業が生産規模の拡大と精製ワークフローの最適化を続ける中、プロテインAレジンの技術革新は、生物製剤製造の費用対効果と持続可能性の向上に重要な役割を果たしています。

プロテインA樹脂市場の成長の原動力は？

プロテインA樹脂市場の成長は、モノクローナル抗体治療薬に対する需要の高まり、バイオ医薬品製造への投資の増加、クロマトグラフィー技術の進歩など、いくつかの要因によってもたらされます。個別化医療や標的生物学的療法の拡大が高純度抗体製造の必要性を煽り、市場の需要をさらに押し上げています。がんや自己免疫疾患などの慢性疾患の増加も生物製剤の採用を加速しており、効率的な精製技術が必要とされています。さらに、バイオシミラーやバイオベッターの出現は、製薬会社が費用対効果の高い精製ソリューションを求めているため、プロテインA樹脂メーカーに新たな機会をもたらしています。シングルユースバイオプロセシングシステムとクロマトグラフィーワークフローの自動化へのシフトは、抗体精製のスケーラビリティと効率をさらに高めています。バイオ医薬品の技術革新が進化を続ける中、プロテインA樹脂市場は次世代生物学的製剤の開発を支援し、持続的な成長が見込まれています。

セグメント

タイプ（組換えプロテインA、天然プロテインA）、材料タイプ（アガロースベースプロテインA、ガラス/シリカベースプロテインA、有機ポリマーベースプロテインA）、用途（抗体精製用途、免疫沈降用途）、最終用途（製薬・バイオテクノロジー企業最終用途、学術研究機関最終用途、その他最終用途）

調査対象企業の例

  • Abcam plc
  • Agarose Bead Technologies
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation（Cytiva）
  • Expedeon Ltd.
  • GenScript Biotech Corporation
  • JSR Life Sciences
  • Kaneka Corporation
  • Merck KGaA
  • Novasep
  • Orochem Technologies Inc.
  • PerkinElmer, Inc.
  • Prometic Life Sciences Inc.
  • Purolite Life Sciences
  • Repligen Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience
  • W. R. Grace & Co.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32713

Global Protein A Resins Market to Reach US$2.3 Billion by 2030

The global market for Protein A Resins estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Recombinant Protein A, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Natural Protein A segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$439.0 Million While China is Forecast to Grow at 5.5% CAGR

The Protein A Resins market in the U.S. is estimated at US$439.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$372.5 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Protein A Resin Market - Key Trends & Drivers Summarized

Why Is Protein A Resin Crucial in Biopharmaceutical Manufacturing?

Protein A resin has become an essential component in biopharmaceutical production, primarily used in affinity chromatography for the purification of monoclonal antibodies (mAbs). The increasing demand for biologics, including monoclonal antibody therapies for cancer, autoimmune diseases, and infectious diseases, has driven the widespread adoption of Protein A resin in pharmaceutical research and drug development. This resin is highly effective in capturing and purifying antibodies with high specificity, ensuring the quality and efficacy of biotherapeutic drugs. As the biopharmaceutical industry continues to expand, companies are investing in advanced purification techniques to enhance drug yield, reduce production costs, and meet stringent regulatory standards. Additionally, the rise of biosimilars and personalized medicine has further increased the demand for efficient antibody purification solutions, making Protein A resin an indispensable tool in modern bioprocessing.

What Challenges Are Impacting the Growth of the Protein A Resin Market?

Despite its critical role in biopharmaceutical purification, the Protein A resin market faces several challenges that impact its scalability and cost efficiency. One of the primary concerns is the high cost associated with Protein A resin production, which significantly adds to the overall expense of monoclonal antibody manufacturing. The limited lifespan of resin columns also presents a challenge, as frequent replacements increase operational costs and waste management concerns. Additionally, the complexity of regulatory compliance in biopharmaceutical manufacturing requires rigorous validation processes, further delaying the adoption of newer resin technologies. The emergence of alternative purification techniques, such as ion-exchange chromatography and mixed-mode chromatography, is also creating competition, as companies explore cost-effective and scalable options. Addressing these challenges requires continued advancements in resin reusability, process optimization, and the development of cost-effective alternatives to Protein A resin in large-scale bioproduction.

How Are Innovations in Chromatography and Bioprocessing Enhancing Protein A Resin Efficiency?

Advancements in chromatography and bioprocessing technology are significantly improving the efficiency and sustainability of Protein A resin. The development of high-capacity and alkali-resistant resins is extending the longevity of purification columns, reducing the frequency of resin replacement and lowering production costs. The integration of continuous chromatography is also revolutionizing antibody purification, enabling biopharmaceutical manufacturers to enhance process efficiency, minimize resin usage, and improve product yield. Additionally, advancements in recombinant Protein A ligands are enhancing resin stability and selectivity, ensuring higher purification efficiency with minimal loss of target molecules. The use of nanotechnology in resin development is further optimizing binding capacity and reducing purification time, making antibody production more cost-effective. As biopharmaceutical companies continue to scale up production and optimize purification workflows, innovations in Protein A resin are playing a crucial role in improving the cost-effectiveness and sustainability of biologics manufacturing.

What Is Driving the Growth of the Protein A Resin Market?

The growth in the Protein A resin market is driven by several factors, including the rising demand for monoclonal antibody therapeutics, increasing investment in biopharmaceutical manufacturing, and advancements in chromatography technologies. The expansion of personalized medicine and targeted biologic therapies is fueling the need for high-purity antibody production, further driving market demand. The increasing prevalence of chronic diseases, such as cancer and autoimmune disorders, has also accelerated the adoption of biologics, necessitating efficient purification techniques. Additionally, the emergence of biosimilars and biobetters is creating new opportunities for Protein A resin manufacturers, as pharmaceutical companies seek cost-effective purification solutions. The shift toward single-use bioprocessing systems and automation in chromatography workflows is further enhancing the scalability and efficiency of antibody purification. As biopharmaceutical innovation continues to evolve, the Protein A resin market is expected to witness sustained growth, supporting the development of next-generation biologic therapies.

SCOPE OF STUDY:

The report analyzes the Protein A Resins market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Recombinant Protein A, Natural Protein A); Material Type (Agarose-based Protein A, Glass / Silica-based Protein A, Organic Polymer-based Protein A); Application (Antibody Purification Application, Immunoprecipitation Application); End-Use (Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abcam plc
  • Agarose Bead Technologies
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Cytiva)
  • Expedeon Ltd.
  • GenScript Biotech Corporation
  • JSR Life Sciences
  • Kaneka Corporation
  • Merck KGaA
  • Novasep
  • Orochem Technologies Inc.
  • PerkinElmer, Inc.
  • Prometic Life Sciences Inc.
  • Purolite Life Sciences
  • Repligen Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience
  • W. R. Grace & Co.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Protein A Resins - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Demand for Monoclonal Antibody Therapeutics Throws the Spotlight on High-Capacity Protein A Resin Solutions
    • Expansion of Biopharmaceutical Manufacturing Pipelines Drives Adoption of Affinity Chromatography Purification Technologies
    • Growth in Biosimilar and Biologics Production Strengthens Business Case for Cost-Effective and Scalable Resin Platforms
    • Advancements in Ligand Engineering and Immobilization Techniques Propel Development of Next-Generation Protein A Resins
    • Increased Emphasis on Process Efficiency and High Binding Capacity Spurs Innovation in High-Flow, High-Density Resin Formats
    • Integration of Protein A Resins into Continuous Bioprocessing Workflows Accelerates Demand for Robust, Reusable Materials
    • Emergence of Single-Use and Prepacked Column Systems Expands Accessibility for Small-Scale and Modular Bioproduction
    • Focus on Downstream Bottleneck Reduction in Biologic Manufacturing Drives Process Optimization Using Protein A Resin
    • Rising Pressure to Lower Cost of Goods Sold (COGS) Strengthens Demand for Long-Life and High-Cycle-Count Resin Variants
    • Growing Investment in Antibody-Drug Conjugates and Novel mAbs Boosts Market for Specialized Resin Solutions
    • Expansion of Contract Development and Manufacturing Organizations (CDMOs) Fuels Large-Volume Resin Procurement
    • Regulatory Emphasis on Purity, Consistency, and Leachables Drives Quality Control in Resin Manufacturing and Validation
    • Adoption of High-Throughput Screening Technologies Enhances Resin Selection and Scale-Up in Process Development
    • Increasing Demand for Flexible and Multi-Product Bioproduction Facilities Spurs Custom Resin Design and Versatility
    • Collaborations Between Resin Manufacturers and Biopharma Innovators Strengthen Co-Development of Application-Specific Resins
    • Focus on Green Chemistry and Sustainable Resin Manufacturing Drives Innovation in Biodegradable and Solvent-Free Processes
    • Rising Use of Protein A Resin in Academic and Government Research Expands Market Beyond Commercial Therapeutics
    • Challenges in Resin Reusability and Cleanability Create Opportunities for Disposable Resin Formats and Smart Monitoring Tools
    • Technological Integration of Smart Sensors and AI in Downstream Processing Drives Real-Time Resin Performance Analytics
    • Growth in Emerging Markets and Regional Biomanufacturing Hubs Expands Global Demand for Localized Resin Supply Chains
    • Surge in Pandemic-Driven Vaccine and Antibody Development Programs Accelerates Strategic Stockpiling of Protein A Resin
    • Standardization of Process Analytical Technology (PAT) in Biomanufacturing Enhances Predictive Control Over Resin Utilization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Protein A Resins Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Protein A Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Protein A Resins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Recombinant Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Recombinant Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Natural Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Natural Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Agarose-based Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Agarose-based Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Glass / Silica-based Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Glass / Silica-based Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Organic Polymer-based Protein A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Organic Polymer-based Protein A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Antibody Purification Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Antibody Purification Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Immunoprecipitation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Immunoprecipitation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • JAPAN
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • CHINA
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • EUROPE
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Protein A Resins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Protein A Resins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • FRANCE
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 66: France Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 70: France Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • GERMANY
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 76: Germany Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Germany 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • ITALY
    • TABLE 82: Italy Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Italy 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 84: Italy Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Italy 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 90: UK Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: UK 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 94: UK Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of Europe 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Protein A Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Asia-Pacific 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Asia-Pacific 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 114: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by Type - Recombinant Protein A and Natural Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of World 6-Year Perspective for Protein A Resins by Type - Percentage Breakdown of Value Sales for Recombinant Protein A and Natural Protein A for the Years 2025 & 2030
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by End-Use - Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of World 6-Year Perspective for Protein A Resins by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Pharma & Biotech Companies End-Use and Academic Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by Material Type - Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Protein A Resins by Material Type - Percentage Breakdown of Value Sales for Agarose-based Protein A, Glass / Silica-based Protein A and Organic Polymer-based Protein A for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Protein A Resins by Application - Antibody Purification Application and Immunoprecipitation Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Protein A Resins by Application - Percentage Breakdown of Value Sales for Antibody Purification Application and Immunoprecipitation Application for the Years 2025 & 2030

IV. COMPETITION